Skip to main content

SYNAPTICS Inc

For the period ended Jun 27, 2026. Filed Aug 10, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Aug 10, 2026

SYNA$117.70+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

(in millions, except share amounts)

Common Stock
SharesAmountAdditional Paid-In CapitalTreasury StockRetained EarningsTotal Stockholders’Equity
Balance at June 202368,687,511$0.1$1,009.2$(878.0)$1,112.1$1,243.4
Net income————125.6125.6
Issuance of common stock for share-based award compensation plans996,480—15.9——15.9
Payroll taxes related to net share settlement of share-based awards——(36.9)——(36.9)
Share-based compensation——118.8——118.8
Balance at June 202469,683,9910.11,107.0(878.0)1,237.71,466.8
Net loss————(47.8)(47.8)
Issuance of common stock for share-based award compensation plans927,854—13.9——13.9
Payroll taxes related to net share settlement of share-based awards——(19.6)——(19.6)
Purchase of capped calls related to the 2031 convertible senior notes——(49.9)——(49.9)
Common stock repurchased———(128.9)—(128.9)
Share-based compensation attributable to acquisition——47.6——47.6
Share-based compensation——112.8——112.8
Balance at June 202570,611,8450.11,211.8(1,006.9)1,189.91,394.9
Net loss————(490.8)(490.8)
Issuance of common stock for share-based award compensation plans1,738,245—17.2——17.2
Payroll taxes related to net share settlement of share-based awards——(48.4)——(48.4)
Common stock repurchased———(92.7)—(92.7)
Share-based compensation——149.3——149.3
Balance at June 202672,350,090$0.1$1,329.9$(1,099.6)$699.1$929.5
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.